BioTechniques is part of Taylor & Francis Group.
Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.
Follow us on social media
Follow us on social media
Follow us on social media
Follow us on social media
Follow us on social media
In this week’s biotech bi-weekly, we explore recent product launches, partnerships and publications that have sparked interest in the biotech space, from a new brain organoid assay to presenting the latest lab automation innovations. Products Unveiling a new brain organoid assay 28bio (LA, USA) has announced the launch of the CNS-3D Induced Alzheimer’s Model, a brain organoid assay enabling researchers to evaluate whether therapeutic candidates can reduce or prevent disease progression in patients. The CNS-3D Induced Alzheimer’s Model includes human neuroimmune organoids and exogeneous amyloid beta oligomers to evaluate Alzheimer’s-relevant phenotypes. This assay-ready solution enables researchers to reproduce complex neuroimmune…
Join our member community for FREE to access a collection of journal and online-only features, including:
Top content
Related tags
BioTechniques is powered by Taylor & Francis Group
Impact Factor 2.2 | CiteScore 2.0
Leave a Reply